Europese Unie - Nederlands - EMA (European Medicines Agency)

virbac s.a. - recombinant omega-interferon van oorsprong van katten - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. bij katten die met fiv waren geïnfecteerd, was de mortaliteit laag (5%) en werd deze niet beïnvloed door de behandeling.

Europese Unie - Nederlands - EMA (European Medicines Agency)

sanofi pasteur msd, snc - polyribosylribitol fosfaat uit haemophilus influenzae type b als prp-ompc, de buitenste membraan eiwit complex van neisseria meningitidis (de buitenste membraan eiwit complex van de b11 stam van neisseria meningitidis subgroep b), geadsorbeerd hepatitis-b-oppervlakte-antigeen geproduceerd in recombinant gistcellen (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccins - procomvax is geïndiceerd voor vaccinatie tegen invasieve ziekte veroorzaakt door haemophilus influenzae type b en tegen infectie veroorzaakt door alle bekende subtypes van hepatitis b-virus bij zuigelingen van 6 weken tot 15 maanden oud.

Europese Unie - Nederlands - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis serogroep b fhbp (recombinant gelipideerd fhbp (factor h bindend eiwit)) subfamilie a; neisseria meningitidis serogroep b fhbp (recombinant gelipideerd fhbp (factor h bindend eiwit)) subfamilie b - meningitis, meningokokken - bacterial vaccines, meningococcal vaccines - trumenba is geïndiceerd voor actieve immunisatie van personen van 10 jaar en ouder om invasieve meningokokkenziekte veroorzaakt door neisseria meningitidis serogroep b te voorkomen.. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Europese Unie - Nederlands - EMA (European Medicines Agency)

intervet international b.v. - cel-geassocieerde live recombinant turkije herpesvirus (stam hvp360), de uiting van de fusie-eiwit van nd-virus en de vp2 eiwit van ibd virus - aviaire herpes virus (marek ' s disease) + aviaire infectieuze bursitis disease virus (gumboro ziekte) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eli lilly benelux - humane, recombinante insuline; insuline isofaan - suspensie voor injectie - 100 iu/ml - humane, recombinante insuline 30 ie/ml; insuline isofaan 70 ie/ml - insulin (human)

Europese Unie - Nederlands - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenza, human - vaccins - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Europese Unie - Nederlands - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals voor aves - kip - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Europese Unie - Nederlands - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals voor canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Europese Unie - Nederlands - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Europese Unie - Nederlands - EMA (European Medicines Agency)

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaccins - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 en 5. 1 in product information document). het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.